|
DE19906744A1
(de)
*
|
1999-02-18 |
2000-08-24 |
Martin Roecken |
Verfahren zur Herstellung antitumoraler Th1-Zellen
|
|
CA2368967A1
(en)
*
|
1999-04-09 |
2000-10-19 |
Biomira, Inc. |
Telomerase-specific cancer vaccine
|
|
DE19917195B4
(de)
*
|
1999-04-16 |
2006-09-28 |
Immatics Biotechnologies Gmbh |
Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor
|
|
WO2001018035A2
(en)
*
|
1999-09-08 |
2001-03-15 |
Transgene S.A. |
Muc-1 derived peptides
|
|
GB9921337D0
(en)
|
1999-09-09 |
1999-11-10 |
Axis Genetics Plc |
Modified plant viruses
|
|
GB0007150D0
(en)
*
|
2000-03-24 |
2000-05-17 |
Lamellar Therapeutics Limited |
Immunotherapeutic methods and compositions
|
|
ES2424131T3
(es)
*
|
2001-03-27 |
2013-09-27 |
Oncothyreon Inc. |
Vacuna para modular respuestas inmunitarias entre T1 y T2
|
|
US7282222B2
(en)
|
2002-03-15 |
2007-10-16 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Methods and compositions for directing cells to target organs
|
|
EP1572918B1
(en)
*
|
2002-04-15 |
2011-10-19 |
Oncothyreon Inc. |
Synthetic glyco-lipo-peptides as vaccines
|
|
US20060142546A1
(en)
*
|
2002-09-05 |
2006-06-29 |
Franz-Georg Hanisch |
Immunogenic muc1 glycopeptides
|
|
CA2501527A1
(en)
*
|
2002-10-10 |
2004-04-22 |
Catherine A. Phillips |
Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
|
|
US20050045205A1
(en)
*
|
2003-08-29 |
2005-03-03 |
Stach Steven R. |
Apparatus and method for cleaning printed circuit boards
|
|
GB0322448D0
(en)
|
2003-09-25 |
2003-10-29 |
Lamellar Therapeutics Ltd |
Using lamellar bodies to modify linear biological macro molecules
|
|
JP5060134B2
(ja)
*
|
2003-12-12 |
2012-10-31 |
ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ・アズ リプレゼンテッド バイ ザ セクレタリー・デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
ヒト細胞傷害性Tリンパ球のエピトープ及びそのMUC−1の非VNTR(non−variablenumberoftandemrepeatsequence)由来のアゴニストエピトープ
|
|
TW201204410A
(en)
|
2004-04-01 |
2012-02-01 |
Oncothyreon Inc |
Mucinous glycoprotein (MUC-1) vaccine
|
|
EP1812052A1
(en)
*
|
2004-11-02 |
2007-08-01 |
Biomedical Research Models, Inc. |
Methods of cancer treatment/prevention using cancer cell-specific surface antigens
|
|
PT2366400E
(pt)
|
2005-06-28 |
2016-02-02 |
Oncothyreon Inc |
Método de tratamento de doentes com uma vacina à base de glicoproteína mucinosa (muc-1)
|
|
WO2010002478A2
(en)
|
2008-07-03 |
2010-01-07 |
University Of Georgia Research Foundation, Inc. |
Glycopeptide and uses thereof
|
|
CA2637600A1
(en)
|
2006-01-17 |
2007-07-26 |
Health Research, Inc. |
Heteroduplex tracking assay
|
|
RU2377994C1
(ru)
*
|
2008-05-21 |
2010-01-10 |
Леонид Валентинович Загребин |
Способ иммунореабилитации онкозаболеваний
|
|
US20100059084A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Austin American Technology Corporation |
Cleaning and testing ionic cleanliness of electronic assemblies
|
|
RU2578420C2
(ru)
|
2010-05-10 |
2016-03-27 |
Эсенд Байофармасьютикалз Пти Лтд |
Иммуностимулирующие и вакцинные композиции
|
|
JP2014518841A
(ja)
|
2011-02-24 |
2014-08-07 |
オンコシレオン インク. |
アジュバントを備えたmuc1ベースのグリコリポペプチドワクチン
|
|
WO2013103658A1
(en)
|
2012-01-03 |
2013-07-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Native and agonist ctl epitopes of the muc1 tumor antigen
|
|
JP2016520073A
(ja)
|
2013-05-14 |
2016-07-11 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Muc−1リポペプチドによるワクチン免疫で肺癌を治療する方法
|
|
WO2015058831A1
(en)
|
2013-10-25 |
2015-04-30 |
Merck Patent Gmbh |
Elevated biomarker expression in lung cancer patients responding to treatment with muc-1 lipopeptide vaccines
|
|
CN110325205B
(zh)
|
2016-12-22 |
2023-08-15 |
库尔生物制药有限公司 |
T细胞调节性多聚体多肽及其使用方法
|
|
US11851471B2
(en)
|
2017-01-09 |
2023-12-26 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
KR20240005989A
(ko)
|
2017-03-15 |
2024-01-12 |
큐 바이오파마, 인크. |
면역 반응을 조절하는 방법
|
|
GB201812647D0
(en)
|
2018-08-03 |
2018-09-19 |
Chancellor Masters And Scholars Of The Univ Of Oxford |
Viral vectors and methods for the prevention or treatment of cancer
|
|
JP2022536581A
(ja)
*
|
2019-06-19 |
2022-08-18 |
キュー バイオファーマ, インコーポレイテッド |
多量体t細胞調節性ポリペプチド及びその使用方法
|
|
IL296209A
(en)
|
2020-05-12 |
2022-11-01 |
Cue Biopharma Inc |
Multimeric t-cell modulatory polypeptides and methods of using them
|
|
JP2023541366A
(ja)
|
2020-09-09 |
2023-10-02 |
キュー バイオファーマ, インコーポレイテッド |
1型真性糖尿病(t1d)を治療するためのmhcクラスii t細胞調節多量体ポリペプチド及びその使用方法
|